Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nye

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
The Journal of Biological Chemistry|January 5, 2000
Regulation of amyloid precursor protein processing by presenilin 1 (PS1) and PS2 in PS1 knockout cellsJ J Palacino, B E Berechid, P Alexander, et al.
Nature Communications|May 1, 2020
Symmetry-controlled edge states in the type-II phase of Dirac photonic latticesGeorgios G Pyrialakos, Nora Schmitt, Nicholas S Nye, et al.
Military Medicine|April 6, 2016
Preventing Exertional Death in Military Trainees: Recommendations and Treatment Algorithms From a Multidisciplinary Working GroupBryant J Webber, Douglas J Casa, Anthony I Beutler, et al.
MSMR|February 1, 2021
Exertional Rhabdomyolysis and Sickle Cell Trait Status in the U.S. Air Force, January 2009-December 2018Bryant J Webber, Nathaniel S Nye, Carlton J Covey, et al.
Journal of Clinical Pharmacology|April 16, 2005
Steady-state pharmacokinetics of galantamine are not affected by addition of memantine in healthy subjectsCaiping Yao, Arash Raoufinia, Michael Gold, et al.
Current Sports Medicine Reports|January 6, 2023
Online Sports Medicine Fellowship Education: The Genesis of a National Program and Year-1 AnalysisJames L Moeller, Jason L Zaremski, Ashwin Rao, et al.
Neuropsychiatric Disease and Treatment|March 5, 2014
Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's diseaseKlaus Hager, Alan S Baseman, Jeffrey S Nye, et al.
Epilepsia|October 1, 2010
Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of ageIhab G Girgis, Partha Nandy, Jeffrey S Nye, et al.
The Journal of Vascular Access|July 27, 2006
Long-term outcomes of a fistula initiative: sustaining "fistula culture"R L McGill, R J Marcus, D A Healy, et al.
Alzheimer'S Research & Therapy|November 17, 2016
Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer's disease: post-hoc analysis of a randomized placebo-controlled studyKlaus Hager, Alan S Baseman, Jeffrey S Nye, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
The Journal of Biological Chemistry|January 5, 2000
Regulation of amyloid precursor protein processing by presenilin 1 (PS1) and PS2 in PS1 knockout cellsJ J Palacino, B E Berechid, P Alexander, et al.
Nature Communications|May 1, 2020
Symmetry-controlled edge states in the type-II phase of Dirac photonic latticesGeorgios G Pyrialakos, Nora Schmitt, Nicholas S Nye, et al.
Military Medicine|April 6, 2016
Preventing Exertional Death in Military Trainees: Recommendations and Treatment Algorithms From a Multidisciplinary Working GroupBryant J Webber, Douglas J Casa, Anthony I Beutler, et al.
MSMR|February 1, 2021
Exertional Rhabdomyolysis and Sickle Cell Trait Status in the U.S. Air Force, January 2009-December 2018Bryant J Webber, Nathaniel S Nye, Carlton J Covey, et al.
Journal of Clinical Pharmacology|April 16, 2005
Steady-state pharmacokinetics of galantamine are not affected by addition of memantine in healthy subjectsCaiping Yao, Arash Raoufinia, Michael Gold, et al.
Current Sports Medicine Reports|January 6, 2023
Online Sports Medicine Fellowship Education: The Genesis of a National Program and Year-1 AnalysisJames L Moeller, Jason L Zaremski, Ashwin Rao, et al.
Neuropsychiatric Disease and Treatment|March 5, 2014
Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's diseaseKlaus Hager, Alan S Baseman, Jeffrey S Nye, et al.
Epilepsia|October 1, 2010
Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of ageIhab G Girgis, Partha Nandy, Jeffrey S Nye, et al.
The Journal of Vascular Access|July 27, 2006
Long-term outcomes of a fistula initiative: sustaining "fistula culture"R L McGill, R J Marcus, D A Healy, et al.
Alzheimer'S Research & Therapy|November 17, 2016
Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer's disease: post-hoc analysis of a randomized placebo-controlled studyKlaus Hager, Alan S Baseman, Jeffrey S Nye, et al.
Pageof 9